Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)

Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts (S.C.H., C.A.B., M.L.R.H., K.L.S., M.A.V., T.H.L.); Neurosolutions Ltd., Coventry, United Kingdom (F.-Y.Z., X.F., H.W., D.C.S.); Department of Physiology, Monash University, Clayton, Victoria, Australia (D.C.S.); and Warwick Medical School, University of Warwick, Coventry, United Kingdom (D.C.S.)